Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.6023
Nov 16 • 3:59 PM ET Dollar change0.0000 Percentage change(0.00%)
Index
-
Market Cap
2.08M
Enterprise Value
-1.07M
Income
-16.28M
Sales
0.00M
Book/sh
0.57
Cash/sh
1.21
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
29
IPO
Nov 01, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
1.07
P/C
0.50
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
1.27
Current Ratio
1.27
Debt/Eq
0.63
LT Debt/Eq
0.10
Option/Short
No / Yes
EPS (ttm)
-20.26
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
74.50% -
Sales past 3/5Y
- -
EPS Y/Y TTM
85.56%
Sales Y/Y TTM
-
EPS Q/Q
95.83%
Sales Q/Q
-
Insider Own
0.87%
Insider Trans
0.00%
Inst Own
2.47%
Inst Trans
-1.29%
ROA
-166.52%
ROE
-380.84%
ROIC
-907.92%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-11.96%
SMA50
-34.90%
SMA200
-83.48%
Trades
Shs Outstand
3.68M
Shs Float
3.64M
52W High
24.80 -97.57%
52W Low
0.59 2.78%
Volatility
9.08% 10.65%
ATR (14)
0.07
RSI (14)
30.87
Beta
1.36
Rel Volume
0.00
Avg Volume
108.50K
Volume
0
Perf Week
-17.84%
Perf Month
-28.04%
Perf Quarter
-52.57%
Perf Half Y
-79.43%
Perf YTD
-96.78%
Perf Year
-97.49%
Perf 3Y
-99.99%
Perf 5Y
-100.00%
Perf 10Y
-
Prev Close
0.60
Price
0.60
Change %
0.00%
Consensus
Strong Buy
Avg. Price Target
$1,920.00
Implied Upside
+318,678.0%
Analysts2incl. previous ratings
Rating Distribution2 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Nov 22, 2023Initiated
HH.C. Wainwright
Buy$11+1,726.3%
Oct 09, 2023Initiated
RRobert W. Baird
Outperform$9+1,394.3%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Camaisa AllanDirectorDec 12 '25Sale1.468501,23776,952Dec 16 07:37 PM
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
CEO & DirectorDr. Eric E. Poma Ph.D.
CFO & Corporate SecretaryMr. Andrew C. Jackson
Pharm.D.Dr. Antonio Fernandez Santidrian Ph.D.
Chief Medical OfficerDr. Guy Travis Clifton M.D.